CLOZAPINE
- Product NDC
- 57664-347
- 11-digit product format
- 576640347
- Labeler code
- 57664
- Product ID
- 57664-347_5dab493f-f2b8-4841-9332-1d9d97451460
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- CLOZAPINE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Application
- ANDA075713
- Marketing category
- ANDA
- Marketing start
- 2002-11-15
- Marketing end
- 0000-00-00
- Substance
- CLOZAPINE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Atypical Antipsychotic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 57664-347-13 | 57664034713 | 500 TABLET in 1 BOTTLE (57664-347-13) | 500 tablet | 2002-11-15 | 0000-00-00 | No | No | Current |
| 57664-347-88 | 57664034788 | 100 TABLET in 1 BOTTLE (57664-347-88) | 100 tablet | 2002-11-15 | 0000-00-00 | No | No | Current |